Dennis L Kasper

USPTO Granted Patents = 45 (Patent Applications = 23)

CIPO Patents = 3 (Patent Applications = 3)

EPO Patents = 2 (Patent Applications = 7)

Average Co-Inventor Count = 2.4

ph-index = 12

Forward Citations = 422(Granted Patents)

Location History:

Newton Center, MA (US) (1980 - 1997)
Newton Centre, MA (US) (1997 - 2002)
Newton, MA (US) (1998 - 2003)
Charleston, MA (US) (2006)
Brookline, MA (US) (2009 - 2020)
Cambridge, MA (US) (2022)
Boston, MA (US) (1993 - 2023)
Charlestown, MA (US) (2006 - 2023)

Company Filing History:

33 out of 1,373

The Brigham and Women's Hospital, Inc.

The General Hospital Corporation

patents

4. 4 out of 1,012

National Research Council of Canada

patents

5. 2 out of 4,550

California Institute of Technology

patents

6. 1 out of 2

The Bingham and Women's Hospital

patents

7. 1 out of 1

The General Hospital Corporation & Brigham and Women's Hospital

Children's Medical Center Corporation

patents

where one patent can have more than one assignee

Years Active: 1980-2025

Loading Chart...

Areas of Expertise:

Gut Microbiome

Immunomodulating Compounds

Glycolipid Compositions

Glycosphingolipids

Zwitterionic Polysaccharides

Conjugate Vaccines

Group B Streptococcus

Polysaccharide Vaccines

Bacterial Antigens

Immunogenic Compositions

Immunomodulating Polymers

Immune System Modulation

45 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12414971 - Methods and compositions to treat and prevent infection (2025-09-16),

2. 11807871 - Complex human gut microbiome cultured in an anaerobic human gut-on-a-chip (2023-11-07),

3. 11622973 - Immunomodulating compounds and related compositions and methods (2023-04-11),

4. 11491181 - Glycolipid compositions and methods of use (2022-11-08),

5. 10857177 - Lipidated PSA compositions and methods (2020-12-08),

6. 10329315 - Glycosphingolipids and methods of use thereof (2019-06-25),

7. 9539281 - Lipid-containing PSA compositions, methods of isolation and methods of use thereof (2017-01-10),

8. 9358302 - Glycoconjugate vaccines (2016-06-07),

9. 9265790 - Zwitterionic immunomodulators for the treatment of asthma and allergy (2016-02-23),

10. 9057070 - [object Object] (2015-06-16),

11. 8206726 - Zwitterionic polysaccharides for promotion of immune system maturation and health (2012-06-26),

12. 8008276 - Use of zwitterionic polysaccharides for the specific modulation of immune processes (2011-08-30),

13. 7858101 - Modified streptococcal polysaccharides and uses thereof (2010-12-28),

14. 7803602 - Method for overexpression of zwitterionic polysaccharides (2010-09-28),

15. 7678558 - Method for overexpression of zwitterionic polysaccharides (2010-03-16),

Title: The Innovative Journey of Dennis L Kasper

Introduction: Dennis L Kasper, a distinguished inventor hailing from Brookline, MA (US), has made significant contributions to the field of innovation through his groundbreaking work in various areas.

Latest Patents: Dennis L Kasper's latest patents showcase his commitment to pushing the boundaries of technology and science, with a focus on improving healthcare solutions and advancing sustainable practices.

Career Highlights: Throughout his illustrious career, Dennis L Kasper has been recognized for his pioneering spirit and inventive mindset. His work has not only revolutionized industries but has also inspired future generations of inventors.

Collaborations: Dennis L Kasper has collaborated with leading experts in the field, fostering a culture of innovation and knowledge-sharing. His partnerships have led to the development of cutting-edge technologies that have had a lasting impact on society.

Conclusion: In conclusion, Dennis L Kasper's passion for innovation, coupled with his relentless drive to create a better world through his inventions, solidifies his position as a trailblazer in the realm of inventors. His legacy will continue to inspire and shape the future of innovation for years to come.

This text is generated by artificial intelligence and may not be accurate.